App-Quantinova.ai

Brain natriuretic peptide (BNP) as molecular marker for bladder, ovarian, and glioblastoma cancers

Cynthia Lee - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Transitional cell carcinoma of the bladder

N/A

Clinical risk prediction in anthracycline cardiotoxicity.

Bonnie Ky - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

Association of physical activity with cardiorespiratory fitness and cardiac function in cancer survivors with chemotherapy-related heart failure.

Karen Basen-Engquist - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Congestive heart failure

N/A

Retrospective analysis of cardiovascular (CV) events following compassionate use of carfilzomib (CFZ) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM).

Shebli Atrash - American Society of Clinical Oncology (ASCO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Multiple Myeloma

Cyclophosphamide

Guanylyl Cyclase A-Targeted Gene Therapy Ameliorates Disease Progression in Autosomal Recessive Polycystic Kidney Disease

Sara J. Holditch - American Society of Gene & Cell Therapy (ASGCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Autosomal recessive polycystic kidney disease

DE-074

10 Versus 20 mL/kg of Transfusion to Compare the Impact of Red Blood Cell Transfusion in Infants With Anemia of Prematurity

Jihyen Hwang - Pediatric Academic Societies (PAS) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

N/A

Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases

Valentina Cannone - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Angiotensin II

Correlates of Spirometery to Invasively Measured Pulmonary Arterial Hemodynamics in Advanced Chronic Heart Failure

Mohammad Alasaad - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Advanced heart failure

N/A

Assessment of the Accuracy of the Diagnosis for Heart Failure in a Large Metropolitan Health Care System and the Impact on Readmission Rates

Sandra Carey - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Prognostic Implications of Serum Chloride Levels in Patients with Stable Heart Failure

Justin L. Grodin - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

Predictive Value of 1, 25-dihydroxyvitamin D to PTH(1-84) Ratios for Cardiovascular Death in Heart Failure

Damien Gruson - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

Parathyroid hormone

Elevated Plasma Interleukin-6, Endothelin-1, and Matrix Metalloproteinase-9 in Heart Failure Patients are Associated With the Need for Advanced Therapies and Mortality

Eitan A. Friedman - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

ILS-969

Early Improvement Of Dyspnea And Neurohormonal Status Using Minute Ventilation-Targeted Adaptive Servo Ventilation in Acute Heart Failure

Boris Arbit - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute decompensated heart failure

N/A

Preoperative Iodine-123 Meta-Iodobenzylguanidine Imaging is a Novel Predictor of Left Ventricular Reverse Remodeling during Left Ventricular Assist Device Treatment

Teruhiko Imamura - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dilated cardiomyopathy

I-123

Frailty Phenotype Is Associated With Survival as Predicted By the Seattle Heart Failure Model in Heart Failure Patients Referred for Advanced Therapies

L. A. Goldraich - International Society for Heart & Lung Transplantation (ISHLT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congestive heart failure

N/A

Normalized Right Isovolumic Relaxation Time and Post-Stress Myocardial Deformation Imaging Reveal Early Signs of Precapillary Pulmonary Hypertension: Insights From a Large Animal Model of Chronic Pressure Overload and Clinical Validation

D. Boulate - International Society for Heart & Lung Transplantation (ISHLT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Dobutamine

Anemic Hypoxia Is Associated With Pulmonary Arterial Hypertension In Patients With Systemic Lupus Erythematosus

Ki-Jo Kim - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Pulmonary arterial hypertension

N/A

Cardiac Magnetic Resonance Imaging in Systemic Lupus Erythematosus

Alexa Meara - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Mycophenolate mofetil

Serum Levels of 1, 25-Dihydroxyvitamin D and the Ratio to PTH(1-84) Are Strong Predictors of Cardiovascular Death in Heart Failure

Damien Gruson - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

Parathyroid hormone

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: preliminary experience in Spain in a series of eight patients

Velazquez M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

Epoprostenol

Filters

387 Abstracts